Kapake (Paracetamol, Codeine Phosphate)

Paracetamol reduces pain and fever by inhibiting central cyclo‑oxygenase enzymes, which lowers prostaglandin production in the brain. Codeine phosphate binds to μ‑opioid receptors in the central nervous system, producing analgesia, sedation, and a mild cough‑suppressing effect. Together they act synergistically, allowing effective symptom control at lower individual doses.

The appropriate dose of Kapake is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition, and response to therapy. Dosage instructions are individualized and must follow the prescriber’s written order; patients should not adjust the dose without medical guidance.

Safety of Kapake in pregnancy or while breastfeeding has not been fully established. Paracetamol is generally considered low‑risk when used at recommended doses, but codeine crosses the placenta and can affect the newborn. Women who are pregnant, planning pregnancy, or nursing should discuss potential risks and benefits with their healthcare provider before using this medication.

To order Kapake, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including any temperature requirements) and assists with import documentation.

Kapake combines a non‑opioid analgesic (paracetamol) with a weak opioid (codeine), offering stronger pain relief than paracetamol alone while typically requiring lower opioid doses than stronger opioids such as morphine. Compared with NSAIDs like ibuprofen, Kapake does not carry the same gastrointestinal or cardiovascular risks, but it does have opioid‑related concerns such as dependence and respiratory depression.

Kapake should be stored at room temperature, below 25 °C (77 °F). Keep the tablets in the original container, protect them from moisture, direct sunlight and excessive heat. Do not store in bathrooms or near kitchen appliances that generate steam or high temperatures.

Kapake is taken orally. The tablets should be swallowed whole with a full glass of water. It can be taken with or without food, but patients who experience stomach upset may prefer to take it with a meal. The exact timing and frequency must follow the prescriber’s instructions.

The most serious risks include respiratory depression, especially when combined with other central nervous system depressants; severe liver injury if paracetamol is taken in excess or in patients with pre‑existing liver disease; and the potential for dependence, tolerance or addiction related to the codeine component. Prompt medical attention is required if breathing becomes shallow, yellowing of the skin occurs, or signs of misuse develop.

Kapake should be avoided in individuals with known hypersensitivity to paracetamol, codeine or any excipients, in patients with severe hepatic impairment, uncontrolled respiratory disorders, or a history of opioid dependence. It is also contraindicated in children under the age specified by local regulations for codeine‑containing products. Clinicians must evaluate each patient’s medical history before prescribing.